跳转至内容
Merck
CN
所有图片(1)

文件

安全信息

SRP0291

Sigma-Aldrich

活性组织蛋白酶L 人

recombinant, expressed in FreeStyle 293-F cells, ≥90% (SDS-PAGE)

别名:

CATL, 主要排泄蛋白 (MEP)

登录查看公司和协议定价


About This Item

UNSPSC代码:
12352204
NACRES:
NA.54

生物来源

human

重组

expressed in FreeStyle 293-F cells

检测方案

≥90% (SDS-PAGE)

形式

aqueous solution

比活

≥3900 pmol/min-μg

分子量

36 kDa

技术

inhibition assay: suitable

适用性

suitable for molecular biology

NCBI登记号

应用

life science and biopharma

运输

dry ice

储存温度

−70°C

基因信息

human ... CTSL(1514)

一般描述

人组织蛋白酶B(基因库登录号:NM_001912),氨基酸18-333,带C-末端HIS标签,MW = 36 kDa,在FreeStyle 293-F细胞中表达。

应用

活性人组织蛋白酶L可用于激活DPP1(组织蛋白酶C)。 活性人组织蛋白酶L已用于一项研究中,该研究确定N-酰基和N-磺酰恶唑烷-2,4-二酮是丝氨酸蛋白酶的假不可逆抑制剂。 活性人组织蛋白酶L也已用于研究人衰老过程中血清中组织蛋白酶B和L活性的作用。

生化/生理作用

Cathepsin L is a cysteine protease, involved primarily in protein breakdown in the lysosome. Cathepsin L degrades nuclear transcription factors and may affect cell cycle regulation. Cathepsin L is also involved in the immune system, specifically in degrading the invariant chain during major histocompatibility complex (MHC) class II processing, a crucial step in antigen presentation. Its expression in the thymus has been demonstrated to be vital for the development of natural killer cells. Additionally, Cathepsin L contributes to recycling processes during axon outgrowth and synapse formation in the developing postnatal central nervous system. Proteases are associated with the development and progression of cancer. Therefore, cathepsin L may be a potential therapeutic target in cancer treatment.

单位定义

一个单位定义为在37℃下每分钟裂解1 pmol底物的酶量

外形

在50 mM MES,400 mM NaCl,pH 5.0和10%甘油中配制。

制备说明

冰上解冻。 首次解冻后,短暂旋转含有酶的试管,以回收试管中的全部内容物。将酶分装成一次性使用的等分试样。 将剩余的未稀释酶分装保存于-70℃。注:酶对冻融循环非常敏感。

法律信息

FreeStyle is a trademark of Invitrogen Corp.

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

常规特殊物品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Jacqueline M Lankelma et al.
Life sciences, 86(7-8), 225-233 (2009-12-05)
Cathepsin L, a cysteine protease, is considered to be a potential therapeutic target in cancer treatment. Proteases are involved in the development and progression of cancer. Inhibition of activity of specific proteases may slow down cancer progression. In this review
Prohormone Thiol Protease
Vivian Y.H. Hook
Handbook of Proteolytic Enzymes (2013)
Jana Ilgová et al.
Molecular and biochemical parasitology, 235, 111248-111248 (2019-12-25)
The gills of the common carp, whose mucosal surface belongs to the key defence mechanisms of piscine immunity, can be infested with both the larval and adult stage of Eudiplozoon nipponicum (Monogenea). Although on their own, monogeneans do not considerably
Ricardo A Orbegozo-Medina et al.
PloS one, 14(2), e0211035-e0211035 (2019-02-02)
Recombinant proteins expressed in E. coli are frequently purified by immobilized metal affinity chromatography (IMAC). By means of this technique, tagged proteins containing a polyhistidine sequence can be obtained up to 95% pure in a single step, but some host
Peter Mundel et al.
Kidney international, 77(7), 571-580 (2009-11-20)
Proteinuria is a major health-care problem that affects several hundred million people worldwide. Proteinuria is a cardinal sign and a prognostic marker of kidney disease, and also an independent risk factor for cardiovascular morbidity and mortality. Microalbuminuria is the earliest

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门